LLY vs WST
By Alex · Tickerpine
Eli Lilly and Company vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | WST |
|---|---|---|
| Price | $1,233.66 | $348.48 |
| Market cap | $1.10T | $24.52B |
| P/E ratio | 41.8 | 45.3 |
| ROE | 102.29% | 19.09% |
| Profit margin | 33.53% | 16.98% |
| Revenue growth | 47.70% | 13.80% |
| Dividend yield | 0.55% | 0.25% |
| Beta | 0.51 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs WST in plain English
- LLY is the bigger company — about 44.9× the market cap of WST.
- LLY is cheaper on earnings (P/E 41.8 vs 45.3).
- LLY earns a higher return on equity (102% vs 19%).
- LLY is growing revenue faster (48% vs 14%).
- LLY has the higher dividend yield (0.55% vs 0.25%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.